Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors.

The article discusses a study which defined clinical outcome and prognostic determinants in patients with brain metastases (BM) from hepatocellular carcinoma (HCC). The study reviewed all patients with HCC and BM treated in Sun Yat-sen University Cancer Center in China between January 1994 and December 2009. The study concluded that BM from HCC is rare and associated with an extremely poor prognosis, and patients with a low RPA class may benefit from aggressive treatment.